Biomedical research towards the prevention and treatment of HIV, tuberculosis, malaria, and other major global health challenges remains our long-term hope for bringing these epidemics to an end. Understanding when new technologies are likely to emerge from the research and development pipeline, and how they might impact ongoing efforts, is vital to ensuring their rapid uptake and integration.
Please join us for a discussion on the status of HIV vaccines and how the U.S. will need to change its response to the global epidemic. Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease (NIAID), will deliver the keynote address. Afterwards, Dr. Fauci will join a distinguished panel with Mr. Mitchell Warren, Executive Director of AVAC, a New York-based advocacy group focused on HIV prevention, and Ms. Margie McGlynn, President and CEO of the International AIDS Vaccine Initiative (IAVI), a product development partnership focused on facilitating discovery of a safe, effective HIV vaccine. Mr. Todd Summers, Senior Advisor at the CSIS Global Health Policy Center, will moderate.
Refreshments will be served after the event closes.